Drug Rescue

VistaStem's stem cell technology platform is based on technologies for controlling the differentiation of human pluripotent stem cells (hPSCs) and producing the multiple types of mature, functional, adult human cells that we use to reproduce complex human biology and disease and assess, in-vitro, the potential therapeutic benefits and safety risks of new chemical entities (NCEs).

We use CardioSafe 3D™, our customized in-vitro bioassay system, for predicting potential cardiotoxicity of drug rescue NCEs early in development, long before costly, high-risk human clinical trials.